Paolo Baroldi

947 total citations
23 papers, 733 citations indexed

About

Paolo Baroldi is a scholar working on Psychiatry and Mental health, Cellular and Molecular Neuroscience and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Paolo Baroldi has authored 23 papers receiving a total of 733 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Psychiatry and Mental health, 5 papers in Cellular and Molecular Neuroscience and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Paolo Baroldi's work include Epilepsy research and treatment (6 papers), Pharmacological Effects and Toxicity Studies (4 papers) and Pharmaceutical studies and practices (4 papers). Paolo Baroldi is often cited by papers focused on Epilepsy research and treatment (6 papers), Pharmacological Effects and Toxicity Studies (4 papers) and Pharmaceutical studies and practices (4 papers). Paolo Baroldi collaborates with scholars based in Italy, United States and Sweden. Paolo Baroldi's co-authors include Eugene Sun, John M. Leonard, Ann Hsu, G. Richard Granneman, J. J. PLATTNER, David Pizzuti, Edith McDonald, Dale J. Kempf, Gondi Kumar and Daniel W. Norbeck and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Neurology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Paolo Baroldi

23 papers receiving 695 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paolo Baroldi Italy 12 353 262 139 108 101 23 733
Jaymin Shah United States 16 368 1.0× 191 0.7× 200 1.4× 111 1.0× 53 0.5× 33 843
Akira Suda Japan 14 234 0.7× 91 0.3× 98 0.7× 116 1.1× 199 2.0× 46 723
Susan T. Hall United States 10 180 0.5× 106 0.4× 228 1.6× 44 0.4× 55 0.5× 14 681
Neil Roskell United States 17 140 0.4× 56 0.2× 64 0.5× 67 0.6× 62 0.6× 31 913
Lorena Cuenca‐Bermejo Spain 12 251 0.7× 114 0.4× 77 0.6× 56 0.5× 29 0.3× 27 587
Martine Monnat Switzerland 11 86 0.2× 54 0.2× 176 1.3× 107 1.0× 230 2.3× 23 697
Joan Albert Arnáiz Spain 14 170 0.5× 116 0.4× 32 0.2× 17 0.2× 28 0.3× 35 618
David Herion United States 15 177 0.5× 91 0.3× 59 0.4× 27 0.3× 77 0.8× 20 1.8k
Eric Mangin United States 14 358 1.0× 141 0.5× 98 0.7× 60 0.6× 23 0.2× 28 757
Haryes A. Funes Spain 8 240 0.7× 243 0.9× 31 0.2× 15 0.1× 26 0.3× 9 427

Countries citing papers authored by Paolo Baroldi

Since Specialization
Citations

This map shows the geographic impact of Paolo Baroldi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paolo Baroldi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paolo Baroldi more than expected).

Fields of papers citing papers by Paolo Baroldi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paolo Baroldi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paolo Baroldi. The network helps show where Paolo Baroldi may publish in the future.

Co-authorship network of co-authors of Paolo Baroldi

This figure shows the co-authorship network connecting the top 25 collaborators of Paolo Baroldi. A scholar is included among the top collaborators of Paolo Baroldi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paolo Baroldi. Paolo Baroldi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Torres, Rosarelis, Marlene Dressman, William G. Kramer, & Paolo Baroldi. (2015). Absolute Bioavailability of Tasimelteon. American Journal of Therapeutics. 22(5). 355–360. 9 indexed citations
2.
Ogilvie, Brian W., Rosarelis Torres, Marlene Dressman, William G. Kramer, & Paolo Baroldi. (2015). Clinical assessment of drug–drug interactions of tasimelteon, a novel dual melatonin receptor agonist. The Journal of Clinical Pharmacology. 55(9). 1004–1011. 18 indexed citations
3.
4.
O’Neal, Welton, et al.. (2014). Topiramate Pharmacokinetics of Extended-Release Once-Daily SPN-538 (Trokendi XR™) in the Elderly (P3.246). Neurology. 82(10_supplement). 1 indexed citations
5.
Torres, Rosarelis, William G. Kramer, & Paolo Baroldi. (2014). Pharmacokinetics of the dual melatonin receptor agonist tasimelteon in subjects with hepatic or renal impairment. The Journal of Clinical Pharmacology. 55(5). 525–533. 12 indexed citations
6.
Brittain, Scott, et al.. (2014). Dose Linearity and Dose Strength Equivalence of Extended-Release Once-Daily SPN-538 (Trokendi XR™) (P3.260). Neurology. 82(10_supplement). 1 indexed citations
7.
8.
9.
Baroldi, Paolo, et al.. (2012). A Phase 2a Randomized, Parallel Group, Dose-Ranging Study of Molindone in Children with Attention-Deficit/Hyperactivity Disorder and Persistent, Serious Conduct Problems. Journal of Child and Adolescent Psychopharmacology. 22(2). 102–111. 21 indexed citations
10.
Achari, Ramanuj, et al.. (1998). Effects of Oral and Intravenous Terazosin and Head‐up Tilt on Blood Pressure Responses in Patients with Hypertension. The Journal of Clinical Pharmacology. 38(6). 545–553. 2 indexed citations
11.
Hsu, Ann, G. Richard Granneman, Guoliang Cao, et al.. (1998). Pharmacokinetic interactions between two human immunodeficiency virus protease inhibitors, ritonavir and saquinavir*. Clinical Pharmacology & Therapeutics. 63(4). 453–464. 135 indexed citations
12.
Kempf, Dale J., Kennan C. Marsh, Gondi Kumar, et al.. (1997). Pharmacokinetic enhancement of inhibitors of the human immunodeficiency virus protease by coadministration with ritonavir. Antimicrobial Agents and Chemotherapy. 41(3). 654–660. 310 indexed citations
13.
Milleri, Stefano, et al.. (1996). Evaluation of personality as a component of the healthy condition of volunteers participating in phase I studies. European Journal of Clinical Pharmacology. 51(3-4). 209–213. 7 indexed citations
14.
Squassante, Lisa, et al.. (1994). A Study of Plasma Disposition Kinetics of Lacidipine After Single Oral Ascending Doses. Journal of Cardiovascular Pharmacology. 23. S94–S97. 5 indexed citations
15.
Barbanti, Gabriele, C.A. Maggi, Patrizia Beneforti, Paolo Baroldi, & Damiano Turini. (1993). Relief of Pain following Intravesical Capsaicin in Patients with Hypersensitive Disorders of the Lower Urinary Tract. British Journal of Urology. 71(6). 686–691. 55 indexed citations
16.
Maestrelli, Piero, Piera Boschetto, S. Crescioli, et al.. (1990). Venous blood platelets decrease during allergen‐induced asthmatic reactions. Clinical & Experimental Allergy. 20(4). 367–372. 13 indexed citations
17.
Maggi, Carlo Alberto, Riccardo Patacchini, Paolo Baroldi, Elvar Theodorsson, & Alberto Meli. (1990). Immunoblockade by a specific tachykinin antiserum of the non‐cholinergic contractile responses in the guinea‐pig isolated bronchus. Journal of Autonomic Pharmacology. 10(3). 173–180. 14 indexed citations
18.
Barone, Domenico, et al.. (1989). Octylonium bromide interacts competitively with the PAF receptor.. PubMed. 15(8). 363–7. 2 indexed citations
19.
Mattei, A, Carlo Ferrari, Paolo Baroldi, et al.. (1988). Prolactin-Lowering Effect of Acute and Once Weekly Repetitive Oral Administration of Cabergoline at Two Dose Levels in Hyperprolactinemic Patients. The Journal of Clinical Endocrinology & Metabolism. 66(1). 193–198. 41 indexed citations
20.
Pontiroli, A. E., et al.. (1987). Inhibition of Basal and Metoclopramide-Induced Prolactin Release by Cabergoline, an Extremely Long-Acting Dopaminergic Drug. The Journal of Clinical Endocrinology & Metabolism. 65(5). 1057–1059. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jaymin Shah Breakdown of academic impact, for papers by Akira Suda Breakdown of academic impact, for papers by Susan T. Hall Breakdown of academic impact, for papers by Neil Roskell Breakdown of academic impact, for papers by Lorena Cuenca‐Bermejo Breakdown of academic impact, for papers by Martine Monnat Breakdown of academic impact, for papers by Joan Albert Arnáiz Breakdown of academic impact, for papers by David Herion Breakdown of academic impact, for papers by Eric Mangin Breakdown of academic impact, for papers by Haryes A. Funes
Rankless by CCL
2026